News

The article on API process research by authors in SPERA PHARMA was published in Tetrahedron.

The article on API process research described by Misayo Sera and Hideya Mizufune in SPERA PHARMA was published in Tetrahedron.
(Integrated Pd-catalyzed cross-coupling strategies for furnishing α-carbolines, Tetrahedron, vol.73 (40), 5946–5958)
This article reports new synthetic methodologies developed through the API process research (conducted at Pharmaceutical Sciences, Takeda Pharmaceutical Company). This kind of convenient and diverse synthetic method for pharmacophore of drug candidates (e.g. heterocycles) as described in the article is expected to support drug discovery. API process R&D capability is one of the strengths in SPERA PHARMA. Utilizing the skills and experiences that SPERA PHARMA has fostered so far, SPERA PHARMA would like to provide solutions for customers’ challenges and optimal synthetic methods, and contribute to accelerating drug discovery research.

(Tetrahedron is the famous scientific journal in the field of organic chemistry. The name of the journal derived from tetrahedron which is associated with carbon indispensable for organic chemistry)